RxDoctor Payments Data

Angelique Vidrine, PA

Physician Assistant · Ville Platte, LANPI 1598115230

Payments from drug & device makers

$432in general payments, 2019–2025

Across 25 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$202
  • Ardelyx, Inc.$58
  • Lilly USA, LLC$33
  • Amgen$32
  • Novartis$20
  • Astellas Pharma US Inc$18
  • plus $69 from 5 others

What the payments were for

  • Food & beverage$432100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$432 in reported general payments places this provider in the 55th percentile of 1,246 physician assistant providers in Louisiana.

See all physician assistant providers in Louisiana

Medicare billing

Part B allowed, 2024
$5,362
Medicare patients
46
Services billed
222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate73$56,036
OzempicSemaglutide50$50,955
TrulicityDulaglutide39$43,957
Trelegy ElliptaFluticasone/Umeclidin/Vilanter59$39,129
LinzessLinaclotide48$36,467
EliquisApixaban54$34,226
RybelsusSemaglutide30$28,721
TradjentaLinagliptin30$15,897
JardianceEmpagliflozin15$9,009
Breo ElliptaFluticasone/Vilanterol17$7,403
Albuterol Sulfate HfaAlbuterol Sulfate226$5,037
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$4,248
Omeprazole420$4,174
Ventolin HfaAlbuterol Sulfate52$3,507
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$3,278

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$16$79,67680 claims
GSKTrelegy Ellipta, Breo Ellipta$16$46,53276 claims
Lilly USA, LLCTrulicity$33$43,95739 claims
AbbVieLinzess$202$36,46748 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,246 physician assistant providers in Louisiana.

Other physician assistant in Ville Platte

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →